These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11350533)

  • 1. Parkinsonism and Parkinson's disease associated with long-term administration of sertraline.
    Pina Latorre MA; Modrego PJ; Rodilla F; Catalán C; Calvo M
    J Clin Pharm Ther; 2001 Apr; 26(2):111-2. PubMed ID: 11350533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonism and elevated lactic acid with sertraline.
    Mendhekar DN; Benuiwal RP; Puri V
    Can J Psychiatry; 2005 Apr; 50(5):301. PubMed ID: 15968847
    [No Abstract]   [Full Text] [Related]  

  • 3. Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.
    Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; Gironell A; García-Sánchez C; Martínez-Corral M
    Eur J Neurol; 2008 Sep; 15(9):953-9. PubMed ID: 18637826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible parkinsonism in a 90-year-old man taking sertraline.
    Schechter DS; Nunes EV
    J Clin Psychiatry; 1997 Jun; 58(6):275. PubMed ID: 9228898
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reversible parkinsonism secondary to the use of sertraline].
    Pina Latorre MA; Zabala López S
    Neurologia; 1998 Nov; 13(9):444-5. PubMed ID: 9883023
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parkinsonism secondary to the use of sertraline].
    Cano A; Roquer J
    Med Clin (Barc); 1995 Dec; 105(20):797-8. PubMed ID: 8558984
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lung infiltrates associated with sertraline administration].
    Salcedo Mingoarranz AL; Puebla Villaescusa A; De Agustín Sierra L; Ramírez Cruz S; Hidalgo Correas FJ; García Díaz B
    Farm Hosp; 2016 Nov; 40(n06):624-626. PubMed ID: 27894233
    [No Abstract]   [Full Text] [Related]  

  • 8. Encephalophaty associated with rasagiline and sertraline in Parkinson's disease: possible serotonin syndrome.
    Duval F; Flabeau O; Razafimahefa J; Spampinato U; Tison F
    Mov Disord; 2013 Sep; 28(10):1464. PubMed ID: 23495033
    [No Abstract]   [Full Text] [Related]  

  • 9. Sertraline-associated hair loss.
    Ghanizadeh A
    J Drugs Dermatol; 2008 Jul; 7(7):693-4. PubMed ID: 18664165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic episodes in a case of Prementrual Dysphoric Disorder on sertraline.
    Santra Dhali R; Banerjee P; Munshi S; Chaudhuri PR
    Indian J Pharmacol; 2015; 47(5):567-8. PubMed ID: 26600652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute angle closure glaucoma after sertraline.
    Ho HY; Kam KW; Young AL; Chan LK; Yu EC
    Gen Hosp Psychiatry; 2013; 35(5):575.e1-2. PubMed ID: 23040863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertraline hepatotoxicity: report of a case and review of the literature.
    Tabak F; Gunduz F; Tahan V; Tabak O; Ozaras R
    Dig Dis Sci; 2009 Jul; 54(7):1589-91. PubMed ID: 18958618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sertraline-induced Hemichorea.
    Gatto EM; Aldinio V; Parisi V; Persi G; Da Prat G; Bullrich MB; Sanchez P; Rojas G
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():518. PubMed ID: 29276648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature.
    Clark DB; Andrus MR; Byrd DC
    Pharmacotherapy; 2006 Feb; 26(2):269-76. PubMed ID: 16466332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin syndrome from sertraline monotherapy.
    Duignan KM; Quinn AM; Matson AM
    Am J Emerg Med; 2020 Aug; 38(8):1695.e5-1695.e6. PubMed ID: 31837902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline-induced galactorrhea: case report and review of cases reported with other SSRIs.
    Nebhinani N
    Gen Hosp Psychiatry; 2013; 35(5):576.e3-5. PubMed ID: 23260337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet function defects and sertraline-induced bleeding: a case report.
    Strumia M; Guerrero F; Maurel-Ribes A; Garcia C; Payrastre B; Bagheri H
    Fundam Clin Pharmacol; 2020 Oct; 34(5):632-636. PubMed ID: 32125025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sertraline-induced ventricular tachycardia.
    Patel NH; Golwala H; Stavrakis S; Schechter E
    Am J Ther; 2013; 20(6):e720-2. PubMed ID: 21768871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
    Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of sertraline discontinuation syndrome in anorexia nervosa.
    Favaro A; Friederici S; Santonastaso P
    J Clin Psychopharmacol; 2001 Oct; 21(5):533-5. PubMed ID: 11593082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.